Yodoksid suppositories vaginas. 0.2g 10 pcs


Yodoksid suppositories vaginas. 0.2g 10 pcs


SKU: 71991850 Categories: , , Tags: ,


Composition Active ingredient: Povidone-iodine (povidone-iodine 30/06) – 200.0 mg (if the activity of povidone-iodine 11% in the case of other drug activity, respectively decrease or increase the number of bases) ;. Excipients: polyethylene oxide basis: macrogol 1500 (polyethylene oxide-1500) – 2.66 g of macrogol-400 (polyoxyethylene-400) – 0.14 g Description: Suppositories from brown to dark brown, torpedo-shaped. Allowed marbling and the presence of air at the exit of the rod and the funnel-shaped recess. Product: 200 mg vaginal suppositories. 5 suppositories placed in blisters of PVC film laminated with polyethylene. 2 blisters together with instructions for medical use of the drug is placed in a cardboard box. Hypersensitivity to iodine and the other ingredients, Thyrotoxicosis (hyperthyroidism), dermatitis herpetiformis Duhring, thyroid adenoma, simultaneous use of radioactive iodine, children up to 8 years. Dosage 200 mg Indications Acute and chronic infectious and inflammatory diseases of the vagina (trichomonazice, fungal, viral, nonspecific, mixed infection); bacterial vaginosis. Prevention of infectious and inflammatory complications before the gynecological interventions (abortion, installation and removal of the IUD, cervical diathermocoagulation, hysterosalpingography, and others). Interaction with other drugs Povidone-iodine is incompatible with oxidizing agents, alkalis and salts with acidic substances. It is not recommended to use povidone-iodine in conjunction with hydrogen peroxide and agents containing mercury, silver and enzymes. Symptoms: for acute iodine intoxication is characterized by: a metallic taste in the mouth, excessive salivation, burning sensation or pain in the mouth or throat; irritation and swelling of the eyes; skin reactions; gastrointestinal disorders and diarrhea; impaired renal function and anuria; circulatory failure; laryngeal edema secondary to asphyxia, pulmonary edema, metabolic acidosis, hypernatremia. Treatment: symptomatic therapy and maintenance of function of vital organs and systems (including electrolyte balance, renal and thyroid). The drugs group: Antiseptic. Pharmacodynamics: antiseptic preparations. Blocking the amino group of cellular proteins. It has a broad spectrum of antimicrobial action. Active against bacteria (including E. coli, Staphylococcus aureus), fungi, viruses, protozoa. The active substance of the preparation – iodo – is complexed with polyvinylpyrrolidone (povidone) relating to iodophors that bind iodine. The concentration of active iodine – 0.1-1%. Upon contact iodo gradually and uniformly released from the skin and mucous membranes, providing a bactericidal effect on microorganisms. At the site of application is the thin colored layer, which persists as long as not all available iodine. Pharmacokinetics: Absorption and distribution When povidone-iodine in contact with the mucous membrane may increase the absorption of iodine and its content in the blood (the concentration returns to the original value after 7-14 days after the last treatment). In patients with normal thyroid function increased absorption of iodine does not cause significant changes in its hormonal function. Excretion Iodine excreted mainly by the kidneys. The half-life (T1 / 2) after intravaginal application is about 48 hours. Pregnancy and breastfeeding Iodine crosses the placental barrier and is excreted in breast milk. Use of the drug is not recommended Yodoksid® with the II trimester of pregnancy and during breastfeeding. Use of the drug in the periods indicated Yodoksid® only possible in the case if the expected benefit to the mother outweighs the potential risk to the fetus and child. If necessary, use of the drug in these cases, treatment is possible for individual medical supervision. In newborns and infants whose mothers used Yodoksid® necessary to control the function of the thyroid gland. Conditions of supply of pharmacies without a prescription. Side-effects are hypersensitivity reactions to the drug in the application site: redness, itching. Allergic reactions, including contact dermatitis to form a fine red psoriasiform bullous elements. In the event of such phenomena the use of the drug should be discontinued. Special instructions: In the presence of blood bactericidal activity of povidone-iodine may decrease. If nemanifestnogo hyperthyroidism and other thyroid diseases (especially in elderly patients), the drug is used only on strict conditions and under constant medical supervision. In connection with the oxidising properties povidone-iodine traces can lead to false positive results of certain types of studies to detect occult blood in feces, as well as blood or glucose in urine. During the application of povidone-iodine may decrease thyroid uptake of iodine, which may affect the results of certain diagnostic tests (e.g., thyroid scintigraphy, determination of protein-bound iodine, measurement using radioactive iodine), and possible interaction with iodine preparations used for the treatment of thyroid diseases. To obtain undistorted results thyroid scintigraphy after prolonged therapy povidone-iodine is recommended to sustain a sufficiently long period of time without the drug. If, during the course of treatment of hyperthyroidism symptoms occur, you should check thyroid function. Caution should be observed at regular application of the drug in patients previously diagnosed with renal insufficiency. Avoid regular use of the drug Yodoksid® in patients receiving lithium drugs. It is recommended to use caution when administered pessaries virgins. skin coloring and tissues is easily washed off with water. Suppositories have spermicidal effect, and therefore not recommended for use in patients who are planning a pregnancy. During the application of suppositories can recommend the use of sanitary napkins. After contact with the product should avoid contact with eyes. It does not affect the ability to drive and other mechanisms. Storage Conditions The protected from light at a temperature not higher than 25 ° C. Keep out of the reach of children. Dosing and dose Intravaginal. Pre-releasing suppository of blisters, it is administered, lying on his back, deep into the vagina. In acute vaginitis – 1 suppository 2 times a day for 7 days, subacute and chronic vaginitis – 1 1 suppository once per day at bedtime for 14 days (regardless of the phase of the menstrual cycle). Info appearance may differ from that depicted in the picture. There are contraindications.

Additional information

Weight0.100 kg




Release Form

rectal suppositories

Active ingredients



200 mg

Amount in a package

There are no reviews yet.

Add your review